CRP and metabolic dysfunction-associated steatotic liver disease: Subsequently, to determine the adverse effects of biogenic amines on liver damage, we tested changes in CRP levels in blood plasma, a marker protein produced by hepatocytes and associated with NAFLD and inflammation [25].